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Abstract
Hyperandrogenism is a risk factor of cerebrovascular diseases as androgens can alter
markedly the regulation of cerebrovascular tone. We examined the combined impact of
androgen excess and vitamin D deficiency (VDD), a common co-morbidity in hyperandro-
genic disorders, on remodeling and testosterone-induced vascular responses of anterior
cerebral arteries (ACA) in order to evaluate the interplay between androgens and VDD in
the cerebral vasculature. Male and female Wistar rats were either fed with vitamin D defi-
cient or vitamin D supplemented diet. Half of the female animals from both groups received
transdermal testosterone treatment. After 8 weeks, vessel lumen, wall thickness and testos-
terone-induced vascular tone of isolated ACA were determined using pressure microangio-
metry and histological examination. Androgen receptor protein expression in the wall of
cerebral arteries was examined using immunohistochemistry. In female rats only combined
VDD and testosterone treatment decreased the lumen and increased the wall thickness of
ACA. In males, however VDD by itself was able to decrease the lumen and increase the wall
thickness. Vascular reactivity showed similar alterations: in females, testosterone con-
stricted the ACA only after combined VDD and hyperandrogenism, whereas in males VDD
resulted in increased testosterone-induced contractions in spite of decreased androgen
receptor expression. In conclusion, a marked interplay between hyperandrogenism and
VDD results in inward remodeling and enhanced testosterone-induced constrictions of cere-
bral arteries, which might compromise the cerebral circulation and thus, increase the risk of
stroke in the long term. In addition, the early cerebrovascular manifestation of VDD appears
to require androgen excess and thus, depends on gender.
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Introduction
Sex steroids have considerable impact on the cerebral circulation [1] since endogenous and
exogenously administered gonadal hormones influence the cerebrovascular tone and blood
perfusion under physiological and pathophysiological conditions [2]. The impact of estradiol
on the cerebral circulation is well known, however, the effect of testosterone on cerebral vessels
is more obscure [1, 2]. Nevertheless, testosterone could be responsible—at least partly—for the
increased risk of cerebrovascular diseases in men [1, 2] and in hyperandrogenic women as
compared to premenopausal healthy women [3].
Effectiveness of vitamin D (VitD) supplementation in the prevention of cardiovascular
events is obscure [4], however, vitamin D deficiency (VDD) appears to be linked to the meta-
bolic syndrome as well as to cardiovascular diseases including hypertension, atherosclerosis
and cerebrovascular disturbances in both genders [5, 6]. VDD can impair vessel morphology
and reactivity [7, 8], probably due to both alterations of gene expression and non-genomic
actions [5]. The role of VitD in the modulation of arterial function has already been described
in several vessel types [8–10]; for instance, both animal [7] and human studies [11] imply the
presence of cerebrovascular impairment in VDD.
Interestingly, 67–85% of women with androgen excess, particularly with polycystic ovary
syndrome (PCOS), are affected by VDD [12], which appears to influence the development of
PCOS due to the alterations of gene transcription and hormonal regulation [12, 13]. In addi-
tion, several studies report that VDD can worsen the cardiovascular manifestation of PCOS
[12]. Both VDD and hyperandrogenism appear to be associated with cerebrovascular disorders
[14–16] partly due to impaired vascular functions [10, 17]. Therefore, a significant interplay is
assumable between VitD and androgens in the cerebral circulation, which might also explain
the gender differences in the vascular manifestation of VDD [8].
In the present study, we hypothesized an interplay between VDD and hyperandrogenism,
assuming a significant role for the vascular effect of androgens in this interaction, which could
lead to early alterations in cerebrovascular morphology and reactivity predicting the manifes-
tation of stroke in the long term. Thus, we aimed to analyze the impact of testosterone (endog-
enous and exogenously administered) and VDD on the morphological and functional
properties of anterior cerebral arteries (ACA) in a rodent model.
Materials and methods
Experimental animal model
Four-week-old Wistar rats (22 males and 46 females) were involved in the experiments. Ani-
mals were housed at constant temperature (22 ± 1˚C) and 12–12 hours light-dark cycle. 11
male and 22 female rats were sorted out randomly and fed with VDD diet (EF R/M, E15312-
24, ssniff Spezialdia¨ten GmbH, Soest, Germany) for eight weeks (♂d- and ♀d- groups, respec-
tively). All other animals received conventional rat chow (SM R/M, S8106-S011, sniff Spezial-
dia¨ten GmbH, Soest, Germany) with per os VitD supplementation (Vigantol, 20.000 IU/mL
cholecalciferol (Merck Serono, Mumbai, India)) providing optimal VitD supply: the daily
VitD intake was 300 IU/100 g b. w. which provided 26.31±2.21 ng/mL serum 25-hydroxyvita-
min D level, whereas VDD diet resulted in 5.63±0.46 ng/mL 25-hydroxyvitamin D level after
eight week of treatment. Half of the female rats from both the VitD sufficient and deficient
groups received transdermal testosterone treatment for eight weeks (T♀D+ and T♀D- groups,
0.033 mg/g b. w. testosterone (Androgel 1%, Laboratories Besins International S.A., Paris,
France)), which increased serum total testosterone levels from 0.46±0.11 ng/mL to 3.61±0.37
ng/mL (the average testosterone level of male rats was 5.87±0.60 ng/mL).
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Table 1 represents the experimental design for all groups. Body weight was measured regu-
larly, and the gain of body weight was calculated. At the age of twelve weeks, blood pressure of
the animals was measured by cannulation of the carotid artery under general anesthesia (pen-
tobarbital, 45 mg/kg b.w., i. p.; Ceva-Phylaxia, Budapest, Hungary). After perfusion via the
carotid artery with heparinized Krebs-Ringer solution and decapitation under anesthesia, the
brain was removed, and ACA segments were prepared under a stereomicroscope (Wild M3Z,
Heerbrugg, Switzerland).
All procedures conformed to the Guide for the Care and Use of Laboratory Animals pub-
lished by the US National Institutes of Health (8th edition, 2011) and the EU-conform Hun-
garian Law on Animal Care (XXVIII/1998). The Institutional Animal Care and Use
Committee of Semmelweis University approved the study protocol (PEI/001/820-2/2015). All
surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to
minimize suffering.
Pressure microangiometry
An approximately 2-mm-long segment of the ACA was isolated and excised, and its morpho-
logical and functional properties were examined using pressure microangiometry [7]. After
equilibration at 50 mmHg intraluminal pressure in normal Krebs-Ringer solution [7], cumula-
tively increasing concentrations of testosterone (Sigma-Aldrich, Darmstadt, Germany) were
applied (10−9 mol/L—10−6 mol/L, 5 min incubation for each step), considering the appropriate
plasma concentrations of the hormone in males and females [10, 18]. Pictures were taken dur-
ing the experiment by a digital camera (Leica DFC 320) connected to an inverted microscope
(Leica, Wetzlar, Germany). The outer and inner diameters of the vessels were measured using
an ImageJ image analyzing software (Image J 1.5 NIH, USA). For calibration, a micrometer
etalon (Wild, Heerbrugg, Switzerland) was applied. Testosterone-induced tone was expressed
as 100�(RinKR-RiTEST)/RinKR, where RiTEST is the inner radius after incubation with testosterone
and RinKR is the inner radius in normal Krebs-Ringer solution.
Histology and immunohistochemistry
Ovaries and ACA segments were fixed freshly with formalin for histological examination;
thereafter, ovaries were stained with hematoxylin and eosin, whereas ACA segments were
either stained also with hematoxylin and eosin or immunostained for androgen receptor (AR).
For immunostaining, artery segments were incubated at 37˚C for 36 min with polyclonal rab-
bit ChIP Grade anti-androgen receptor antibody (ab74272, AB_1280747; Abcam, Cambridge,
MA, USA) [19] using the Ventana Benchmark Ultra System after deparaffinization and anti-
gen retrieval (97˚C, 8 min). The UltraView Universal DAB Detection Kit (Ventana Medical
Systems, Inc., Tucson, AZ, USA) was used for detecting primary antibodies. Data collections
Table 1. Experimental design.
SEX ♀ ♂
VITAMIN D + - + -
TESTOSTERONE TREATMENT + - + - - -
SYMBOL T♀D+
(n = 12)
♀D+
(n = 12)
T ♀d-
(n = 11)
♀D-
(n = 11)
♂D+
(n = 11)
♂D-
(n = 11)
♀D+ and ♀D- stand for female rats that received conventional rat chow and vitamin D deficient diet, respectively. T♀D+ and T♀d- symbolize testosterone treated
females with vitamin D supply and with vitamin D deprivation, respectively. ♂D+ and ♂D- stand for male rats that received conventional rat chow and vitamin D
deficient diet, respectively.
https://doi.org/10.1371/journal.pone.0216951.t001
Interplay between androgens and VitD in cerebral vessels
PLOS ONE | https://doi.org/10.1371/journal.pone.0216951 May 13, 2019 3 / 13
were made by a microscope (Zeiss AxioImager.A1) coupled with a video-camera (Zeiss Axio-
CAm MRc5 CCD), and pictures were analyzed with ImageJ image analyzing software (Image J
1.5 NIH, USA). The wall thickness of arteries was determined on hematoxylin and eosin
stained segments. Pictures of AR staining were analyzed using the „Color deconvolution” pro-
file of ImageJ. The percentage of positively stained tissue area to total area of the section (area
%) was calculated.
Statistical analysis
All data are presented as mean ± SEM. Normal distribution of datasets was checked with Sha-
piro-Wilk test. Statistical analysis for the artery geometry of males was performed using Stu-
dent’s t test, whereas for any other parameters two-way ANOVA followed by Tukey’s post hoc
test was used, and p<0.05 was considered statistically significant. GraphPad Prism version 6.0
was used for statistical analysis.
Results
Gain of body weight, blood pressure and ovarian histology
Male and hyperandrogenic female rats had enhanced weight gain as compared to females (Fig
1), indicating that the gain of body weight was impacted by gender and hyperandrogenism.
Vitamin D status, however, did not influence weight gain (Fig 1). Arterial blood pressure was
not affected by either treatment: mean arterial pressure was 130.5±2.7 mmHg in male whereas
116.2±6.3 mmHg in female and 111.1±2.0 mmHg in hyperandrogenic female rats. Vitamin D
status had no influence on blood pressure as well. The ovaries were stained with hematoxylin
and eosin for histological examination. Hyperandrogenic female rats had multiple small-sized
primordial follicles in the ovaries (Fig 2), indicating that hyperandrogenism impairs follicle
maturation independently from vitamin D status.
Fig 1. Gain of body weight. Hyperandrogenism enhanced the weight gain of female rats (�p = 0.0031, 0.0047 and
0.0067 vs. ♀D+ for T♀D+ (g), T♀D+ (%) and T♀D- (%), respectively; n = 10–11; two-way ANOVA followed by Tukey’s
post hoc test). Male rats had increased weight gain as compared to females (łp<0.0001 vs. ♀D+, #p<0.0001 vs. ♀D-;
n = 10–11; two-way ANOVA followed by Tukey’s post hoc test). VDD influenced the weight gain neither in female nor
in male animals. Gain of body weight (g) = final body weight (g)—initial body weight (g). Gain of body weight (%) =
100�(final body weight (g)—initial body weight (g))/initial body weight (g).
https://doi.org/10.1371/journal.pone.0216951.g001
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Arterial geometry
Morphological parameters of the cerebral arteries were measured under physiological condi-
tions. No statistically significant difference was found in the lumen cross sectional area as a
function of gender (22173±2602 μm2 and 26745±3542 μm2 for ♀D+ and ♂D+ groups, respec-
tively). In female rats neither VDD nor androgen excess resulted in a significant change of the
lumen cross sectional area (Fig 3A). Surprisingly, however, combined VDD and hyperandro-
genism decreased markedly the lumen of cerebral arteries of female rats (Fig 3A), indicating
that VDD results in increased active tension and/or inward remodeling only in the presence of
testosterone. Accordingly, ACAs of ♂D- rats had significantly decreased lumen cross sectional
area as compared to those of ♂D+ animals (Fig 3B).
To gain further insight into the mechanism (increased vascular tone vs. remodeling)
responsible for the above-mentioned alterations in vessel lumen, the wall thickness of arteries
was determined on hematoxylin and eosin stained sections of the ACA (Fig 3C and 3E). VDD
caused an increase in the wall thickness of males (Fig 3F); however, in females, wall thickness
was only increased by combined VDD and androgen excess (Fig 3D). These results indicate
that the increase in wall thickness could be responsible for the observed changes in cross sec-
tional area. In addition, this VDD-induced inward remodeling appears to require the presence
of androgens.
Vasoactive effects of acute testosterone application
Testosterone has been reported recently to evoke acute vasoactive effects, although with high
variability depending on species and vascular region [20–23]. In our present study, testoster-
one appeared to induce stronger constrictions of the ACA in females as compared to males.
Interestingly, in vessels of T♀D+ and ♀D- animals the contractile effect of testosterone
remained unaltered as compared to ♀D+ rats (Fig 4A). In contrast, combined VDD and
Fig 2. Ovarian histology. Representative images of ovaries stained with hematoxylin and eosin. The ovaries of T♀D+
and T♀D- animals are characterized by increased number of small-sized primordial follicles resembling the
manifestation of PCOS.
https://doi.org/10.1371/journal.pone.0216951.g002
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androgen excess resulted in a more than two-fold increase of testosterone-induced vasocon-
striction (Fig 4A). In accordance, testosterone caused vasoconstriction of arteries prepared
from ♂D- but not from ♂D+ rats (Fig 4B). Therefore, the acute vasoactive effect of testosterone
appears to depend both on gender and VitD status, and hyperandrogenic VitD-deficient
female animals are the most prone to cerebrovascular constriction.
Androgen receptor immunohistochemistry
Finally, to examine the possible role of VitD in the modulation of cerebrovascular AR protein
expression, the percentage of positively stained area in the vessel wall was determined. The
expression of AR protein was not affected by VDD in females, however it was higher in the
vessel wall of VitD-sufficient males as compared to females (Fig 5), implying a marked gender
difference in the protein expression level of AR in cerebral arteries. Interestingly, a significant
decrease in AR protein expression was determined in ♂D- as compared to ♂D+ animals
(Fig 5).
Discussion
The association between vascular disorders and VDD [5, 6, 24, 25] as well as androgen excess
[3, 26] has long been known, however the combined effect of those on cerebral arteries and the
mechanism responsible for the increased risk of stroke has not been completely revealed yet.
The results we present here indicate for the first time a marked interplay between androgens
Fig 3. Cerebral artery geometry. (A) The combined effect of VDD and hyperandrogenism significantly decreased the
lumen cross sectional area of female rats (�p = 0.027 vs. ♀D+; #p = 0.034 vs. T♀D+; n = 10–11; two-way ANOVA
followed by Tukey’s post hoc test). (B) In males, VDD resulted in decreased lumen cross sectional area under
physiological conditions (�p = 0.033 vs. ♂D+, n = 10–11; Student’s t test). (C) Representative images of cerebral
arteries of female rats stained with hematoxylin and eosin. (D) The combined effect of VDD and androgen excess
caused an increase in wall thickness of female rats (�p = 0.010 vs. ♀D+; n = 5–7; two-way ANOVA followed by Tukey’s
post hoc test). (E) Representative images of cerebral arteries of male rats stained with hematoxylin and eosin. (F) VDD
significantly increased the wall thickness of arteries in male rats (�p = 0.032 vs. ♂D+, n = 5–7; Student’s t test).
https://doi.org/10.1371/journal.pone.0216951.g003
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Fig 4. Testosterone-induced acute vascular responses. (A) Acute testosterone application resulted in increased
vasoconstriction in the ACA of female rats subjected to combined VDD and hyperandrogenism (T♀D-) (�p = 0.015
and 0.016 vs. ♀D+ for 10−7 and 10−6 mol/L concentration, respectively; #p = 0.024 vs. ♀D-, ##p = 0.009, 0.004 and 0.003
vs. ♀D- for 10−8, 10−7 and 10−6 mol/L concentration, respectively; łp = 0.017 and 0.013 vs. T♀D+ for 10−9 and 10−8 mol/
L concentration, respectively; łłp = 0.007 and 0.004 vs. T♀D+ for 10−7 and 10−6 mol/L concentration, respectively;
n = 10–11; two-way ANOVA followed by Tukey’s post hoc test). (B) In males, VDD significantly increased the
testosterone-induced tone (�p = 0.030, 0.012, 0.012 and 0.025 vs. ♂D+ for 10−9, 10−8, 10−7 and 10−6 mol/L
concentration, respectively; n = 10–11; two-way ANOVA followed by Bonferroni’s post hoc test). (C-D)
Representative images of the anterior cerebral artery showing the testosterone induced vasoconstriction in female rats
subjected to combined VDD and androgen excess. (C) Anterior cerebral artery segment under physiological
conditions (in normal Krebs-Ringer solution). (D) Anterior cerebral artery segment after the application of 10−6 mol/L
testosterone. Testosterone-induced tone (%) = 100�(RinKR-RiTEST)/RinKR, where RiTEST is the inner radius after
incubation with testosterone and RinKR is the inner radius in normal Krebs-Ringer solution.
https://doi.org/10.1371/journal.pone.0216951.g004
Fig 5. Evaluation of immunohistochemical staining of arteries. (A) Representative immunohistochemical images of
cerebral arteries stained for AR. (B) In females, VDD did not alter the expression of the AR protein in the vessel wall of
arteries; in contrast, in males VDD significantly decreased the expression of AR (�p = 0.008 vs. ♂D+, n = 4–7; two-way
ANOVA followed by Tukey’s post hoc test). In addition, the expression of the AR protein was impacted by gender:
expression significantly decreased in females as compared to males (#p = 0.016 vs. ♀D+; n = 4–4; two-way ANOVA
followed by Tukey’s post hoc test).
https://doi.org/10.1371/journal.pone.0216951.g005
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and VDD in the cerebral circulation characterized by an increased vascular reactivity to andro-
gens. Interestingly, cerebrovascular remodeling induced by VDD appears to require high
androgen levels, which may explain the relative resistance of VitD-sufficient females to cere-
brovascular disorders as compared to males. In addition, combined VDD and hyperandrogen-
ism result in increased testosterone-induced vasoconstriction, which may compromise the
maintenance of optimal cerebrovascular tone under physiological conditions [2].
Hyperandrogenism may lead to cerebrovascular impairment [27] probably due to the long-
term genomic effects of excess androgen [2]. VDD is also linked to cerebrovascular disorders
particularly via impaired vessel morphology and reactivity [2, 6–8, 28–30]. In our study, how-
ever, neither VDD nor androgen excess alone caused alterations in vessel lumen and wall
thickness of female rats, indicating that neither disorder alone causes remodeling in the cere-
bral arteries of females, at least not within 8 weeks. On the contrary, some studies report that
androgen excess leads to the alteration of either diameter or wall thickness in peripheral vessels
[31–33], therefore the impact of hyperandrogenism on vascular remodeling may depend on
vessel type. Surprisingly, in males the endogenous physiological androgen level together with
VDD decreased the lumen and increased the wall thickness of cerebral arteries. Similar remod-
eling was observed in females with combined VDD and androgen excess. These results indi-
cate that androgen excess must be necessary for the development of the cerebrovascular
consequences of VDD, implying a possible interaction between these two factors. VDD
appears to induce similar alterations in hyperandrogenic females to those in males, however
the mechanism might depend on gender. Cerebrovascular contractility of arteries of VDD
males was shown to increase [7], but in hyperandrogenic females VDD had no such effect
[34]. Therefore, in males, in addition to arterial remodeling, the enhanced vascular reactivity
to vasoconstrictor agents could contribute to the decreased cerebral vessel lumen indicating
that gender differences might alter the cerebrovascular manifestation of VDD. VDD and
hyperandrogenism have been reported to be associated with hypertension [6, 25, 35], which
could induce cerebrovascular alterations, however, neither treatment impacted the blood pres-
sure of animals in our present study. Therefore, we could exclude the possibility that the
observed vascular changes would be secondary consequences of VDD/hyperandrogenism-
induced hypertension.
Several studies report an interplay between androgens and VitD in the regulation of pros-
tate cancer cells [36–38], chondrocyte [39] and vascular cell proliferation [40]. The interaction
might be attributed to a cross-talk between AR- and VitD-receptor-mediated gene expression,
as VitD and androgens have many common target genes, the transcription of which they mod-
ulate together [41, 42]. Furthermore, several transcription factor-mediated signaling pathways
are only active, when both hormones are present [42], and VitD also appears to impact the
expression of AR [36, 39]. Therefore, we determined the expression of the AR protein in the
cerebral arteries of VDD animals. VDD resulted in decreased AR protein expression in the
artery wall of males but, surprisingly, not in that of females. The decreased protein expression
might be deleterious in males, as endogenous androgens may protect against vascular remod-
eling [43, 44], atherogenesis [44–46] and thrombosis [47]; furthermore, it could also contribute
to the preservation of NO bioavailability [43]. On the contrary, in females, VDD did not alter
AR protein expression, which supports the findings that (i) short-term VDD alone does not
cause alterations in cerebral vessels of females, and (ii) men are more seriously affected by the
cerebrovascular consequences of VDD than healthy premenopausal women.
Long-term treatment with androgens results in increased vascular tone in females [48] as
well as in male orchiectomized rats [49]. However, testosterone is reported to have also rapid
short-term vasoactive effects [2], particularly in peripheral vessels [21–23]. Ex vivo, direct
application of pharmacological doses of testosterone appears to evoke a rapid decrease in
Interplay between androgens and VitD in cerebral vessels
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vascular tone [1]–due to the activation of an uncharacterized “non-classical” membrane-
bound receptor or to an interaction with ion channels [2]. The impact of acute testosterone
application on cerebral arteries and particularly the effect of chronic androgen excess and
VDD on the rapid short-term actions of testosterone, however, have not been revealed yet. As
androgens contribute markedly to the cerebrovascular manifestation of VDD, their acute vas-
cular effect might also be altered by VDD. Therefore, we analyzed the vascular effect of acute
testosterone application on cerebral arteries and its dependence on VitD and androgen status.
In female animals, similarly to the alterations in vessel morphology, only the combined effect
of VDD and androgen excess enhanced the testosterone-induced vascular tone, independently
from the applied concentrations. However, in VDD males testosterone caused marked con-
tractions, which could probably be a consequence of the increased vascular contractility in
VDD [7]. These results imply that androgen excess in females or physiological androgen levels
in males are a prerequisite for the enhancement of acute testosterone-induced tone in VDD.
In addition, the effect of testosterone on cerebral arteries might depend on gender under nor-
mal VitD and physiological androgen status: acute testosterone application caused cerebral
vasoconstriction in females, but not in males. Thus, physiological concentrations of testoster-
one (in the nanomolar range) [18] do not compromise the cerebral circulation in males. A
similar neutral effect was determined in coronary arteries: testosterone did not change the ves-
sel tone [22] [23], only impaired endothelium-dependent relaxation [22] and potentiated ago-
nist-induced contraction [23]. On the contrary, in the present study both physiological (10−9
mol/L) and supraphysiological concentrations (10−8–10−6 mol/L) of testosterone [18] induced
vasoconstrictions in females. These results indicate that, in addition to vascular remodeling,
the testosterone-induced tone caused by VDD and hyperandrogenism might lead to cerebro-
vascular disorders, as sex steroids may contribute markedly to the maintenance of cerebrovas-
cular tone and reactivity [2].
Both hyperandrogenism and VDD are associated reportedly with cerebrovascular disorders
[14, 15]; however, the present study shows that they synergistically cause deleterious alterations
in the morphology and reactivity of ACA within a relatively short time, which could facilitate
the development of cerebrovascular diseases or aggravate their outcomes. Although cerebral
infarctions localized in the frontal territory are relatively rare, impaired regulation of the ACA
could lead to serious cognitive and executive impairments [50], which might be aggravated by
combined VDD and androgen excess. However, in addition to ACA, both disorders impair
presumably other vascular regions of cerebral circulation including the microcirculation,
which might contribute for instance to blood-brain barrier disruption after stroke as it was
reported in VDD by a recent study [51]. Surprisingly, elevated androgen levels appear to be
required for the early cerebrovascular manifestation of VDD, which might imply that post-
menopausal and hyperandrogenic women are at increased risk of the development of stroke
induced by VDD. These findings underline the importance of the prevention of VDD in
humans and encourages further examination of the interplay between VDD and androgen
excess in cardiovascular disorders.
Conclusions
The present study demonstrates a marked interplay between androgen excess and VDD in the
cerebral circulation, which impairs the morphology and reactivity of cerebral arteries and may
therefore lead to stroke in the long term. We propose that the cerebrovascular manifestation of
VDD requires androgens and is thus gender-dependent. In addition, the combined effect of
VDD and hyperandrogenism appears to lead to impaired testosterone-induced vascular
responses, which might compromise the cerebral circulation.
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